Stock Track | Harrow Health Plunges 15.66% in Pre-Market on Earnings Miss and Weak 2026 Guidance

Stock Track

Mar 03

Harrow Health Inc. (HROW) experienced a significant pre-market plunge of 15.66% on Tuesday, extending losses from the previous trading session.

The sharp decline follows the company's release of its fourth-quarter 2025 financial results, which revealed earnings that fell significantly short of analyst expectations. Harrow reported Q4 earnings per share of $0.17, missing consensus estimates ranging from $0.37 to $0.38 by a wide margin.

Adding to investor concerns, the company issued its 2026 revenue guidance in the range of $350 million to $365 million, which is substantially below analyst consensus expectations of approximately $386 million to $391 million. This combination of an earnings miss and weaker-than-anticipated forward outlook has prompted continued selling pressure in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1170641351"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170641351\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170641351?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 17:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170641351","market":"us","top_or_hot":-1,"title":"Stock Track | Harrow Health Plunges 15.66% in Pre-Market on Earnings Miss and Weak 2026 Guidance","media":"Stock Track","content":"<p>Harrow Health Inc. (HROW) experienced a significant pre-market plunge of 15.66% on Tuesday, extending losses from the previous trading session.</p><p>The sharp decline follows the company's release of its fourth-quarter 2025 financial results, which revealed earnings that fell significantly short of analyst expectations. Harrow reported Q4 earnings per share of $0.17, missing consensus estimates ranging from $0.37 to $0.38 by a wide margin.</p><p>Adding to investor concerns, the company issued its 2026 revenue guidance in the range of $350 million to $365 million, which is substantially below analyst consensus expectations of approximately $386 million to $391 million. This combination of an earnings miss and weaker-than-anticipated forward outlook has prompted continued selling pressure in pre-market trading.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Harrow Health Plunges 15.66% in Pre-Market on Earnings Miss and Weak 2026 Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Harrow Health Plunges 15.66% in Pre-Market on Earnings Miss and Weak 2026 Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-03 17:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Harrow Health Inc. (HROW) experienced a significant pre-market plunge of 15.66% on Tuesday, extending losses from the previous trading session.</p><p>The sharp decline follows the company's release of its fourth-quarter 2025 financial results, which revealed earnings that fell significantly short of analyst expectations. Harrow reported Q4 earnings per share of $0.17, missing consensus estimates ranging from $0.37 to $0.38 by a wide margin.</p><p>Adding to investor concerns, the company issued its 2026 revenue guidance in the range of $350 million to $365 million, which is substantially below analyst consensus expectations of approximately $386 million to $391 million. This combination of an earnings miss and weaker-than-anticipated forward outlook has prompted continued selling pressure in pre-market trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HROW","symbol_name":"Harrow Health Inc","start_time":0,"source_url":"","article_id":"1170641351","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170641351","pubTimestamp":1772529248,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Harrow Health Inc. (HROW) experienced a significant pre-market plunge of 15.66% on Tuesday, extending losses from the previous trading session.The sharp decline follows the company's release of its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HROW":"Harrow Health Inc"},"translate_title":"个股追踪|Harrow Health盘前暴跌15.66%，因盈利未达预期且2026年指引疲弱","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":1},"content_text":"Harrow Health Inc. (HROW) experienced a significant pre-market plunge of 15.66% on Tuesday, extending losses from the previous trading session.The sharp decline follows the company's release of its fourth-quarter 2025 financial results, which revealed earnings that fell significantly short of analyst expectations. Harrow reported Q4 earnings per share of $0.17, missing consensus estimates ranging from $0.37 to $0.38 by a wide margin.Adding to investor concerns, the company issued its 2026 revenue guidance in the range of $350 million to $365 million, which is substantially below analyst consensus expectations of approximately $386 million to $391 million. This combination of an earnings miss and weaker-than-anticipated forward outlook has prompted continued selling pressure in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}